Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Patterns of Retinal Damage Facilitate Differential Diagnosis between Susac Syndrome and MS.
Anti-integrin therapy for multiple sclerosis.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Gray matter is targeted in first-attack multiple sclerosis.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Assessing walking disability in multiple sclerosis.
The microglial sensome revealed by direct RNA sequencing.
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MS.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.

Pages